These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 31367187)
141. The xc- cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance. Lo M; Ling V; Wang YZ; Gout PW Br J Cancer; 2008 Aug; 99(3):464-72. PubMed ID: 18648370 [TBL] [Abstract][Full Text] [Related]
142. CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells. Lin YD; Chen S; Yue P; Zou W; Benbrook DM; Liu S; Le TC; Berlin KD; Khuri FR; Sun SY Cancer Res; 2008 Jul; 68(13):5335-44. PubMed ID: 18593935 [TBL] [Abstract][Full Text] [Related]
143. Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin. Son YG; Kim EH; Kim JY; Kim SU; Kwon TK; Yoon AR; Yun CO; Choi KS Cancer Res; 2007 Sep; 67(17):8274-84. PubMed ID: 17804742 [TBL] [Abstract][Full Text] [Related]
144. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells. Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158 [TBL] [Abstract][Full Text] [Related]
145. Apoptosis: a review of programmed cell death. Elmore S Toxicol Pathol; 2007 Jun; 35(4):495-516. PubMed ID: 17562483 [TBL] [Abstract][Full Text] [Related]
146. The farnesyltransferase inhibitor lonafarnib induces CCAAT/enhancer-binding protein homologous protein-dependent expression of death receptor 5, leading to induction of apoptosis in human cancer cells. Sun SY; Liu X; Zou W; Yue P; Marcus AI; Khuri FR J Biol Chem; 2007 Jun; 282(26):18800-9. PubMed ID: 17493934 [TBL] [Abstract][Full Text] [Related]
147. Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein. Karikari CA; Roy I; Tryggestad E; Feldmann G; Pinilla C; Welsh K; Reed JC; Armour EP; Wong J; Herman J; Rakheja D; Maitra A Mol Cancer Ther; 2007 Mar; 6(3):957-66. PubMed ID: 17339366 [TBL] [Abstract][Full Text] [Related]
148. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Fulda S; Debatin KM Oncogene; 2006 Aug; 25(34):4798-811. PubMed ID: 16892092 [TBL] [Abstract][Full Text] [Related]
149. Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. Lecker SH; Goldberg AL; Mitch WE J Am Soc Nephrol; 2006 Jul; 17(7):1807-19. PubMed ID: 16738015 [No Abstract] [Full Text] [Related]
150. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Krueger A; Baumann S; Krammer PH; Kirchhoff S Mol Cell Biol; 2001 Dec; 21(24):8247-54. PubMed ID: 11713262 [No Abstract] [Full Text] [Related]
151. Apoptosis in cancer. Lowe SW; Lin AW Carcinogenesis; 2000 Mar; 21(3):485-95. PubMed ID: 10688869 [TBL] [Abstract][Full Text] [Related]
152. Emerging roles of caspase-3 in apoptosis. Porter AG; Jänicke RU Cell Death Differ; 1999 Feb; 6(2):99-104. PubMed ID: 10200555 [TBL] [Abstract][Full Text] [Related]